QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kobayashi, K. Articles by Chiba, K. Search for Related Content PubMed PubMed Citation Articles by Kobayashi, K. Articles by Chiba, K.

SHORT COMMUNICATION

SELECTIVITIES OF HUMAN CYTOCHROME P450 INHIBITORS TOWARD RAT P450 ISOFORMS: STUDY WITH cDNA-EXPRESSED SYSTEMS OF THE RAT

Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba (K.K., K.U, K.C); and Daiichi Pure Chemicals Co. Ltd., Tokyo (N.S), Japan

The aim of this study was to determine the selectivities of chemical inhibitors for human cytochrome P450 (P450) isoforms toward the corresponding rat P450 isoforms by using cDNA-expressed rat P450s (CYP1A2, CYP2A1, CYP2C6, CYP2C11, CYP2D2, CYP2E1, CYP3A1, and CYP3A2). Among the inhibitor probes for human P450s used in this study, only sulfaphenazole showed a selective inhibitory effect on the activity of the corresponding rat P450 isoform (CYP2C6). Furafylline also preferentially inhibited the activity of rat CYP1A2. However, methoxalen and ketoconazole more strongly inhibited the activities of other P450 isoforms than those of the corresponding rat P450 isoforms, CYP2A1 and CYP3A1/2, respectively. On the other hand, quinidine and aniline had little effect on the activities of the corresponding rat P450 isoforms, CYP2D2, and rat CYP2E1, respectively. These results suggest that chemical probes that have been used for human P450 isoforms do not always exhibit the same selectivity for the corresponding rat P450 isoforms. However, it appears that sulfaphenazole can be used as a selective inhibitor for rat CYP2C6. In addition, furafylline may also be a relatively selective inhibitor for rat CYP1A2.

This article has been cited by other articles:

				J.-W. Zhang, Y. Liu, J.-Y. Zhao, L.-M. Wang, G.-B. Ge, Y. Gao, W. Li, H.-T. Liu, H.-X. Liu, Y.-Y. Zhang, et al. Metabolic Profiling and Cytochrome P450 Reaction Phenotyping of Medroxyprogesterone Acetate Drug Metab. Dispos., November 1, 2008; 36(11): 2292 - 2298. [Abstract] [Full Text] [PDF]

				K. Grime, P. J. H. Webborn, and R. J. Riley Functional Consequences of Active Hepatic Uptake on Cytochrome P450 Inhibition in Rat and Human Hepatocytes Drug Metab. Dispos., August 1, 2008; 36(8): 1670 - 1678. [Abstract] [Full Text] [PDF]

				V. M. Lakshmi, F. F. Hsu, and T. V. Zenser N-Demethylation Is a Major Route of 2-Amino-3-Methylimidazo[4,5-f]quinoline Metabolism in Mouse Drug Metab. Dispos., June 1, 2008; 36(6): 1143 - 1152. [Abstract] [Full Text] [PDF]

				J.-W. Zhang, G.-B. Ge, Y. Liu, L.-M. Wang, X.-B. Liu, Y.-Y. Zhang, W. Li, Y.-Q. He, Z.-T. Wang, J. Sun, et al. Taxane's Substituents at C3' Affect Its Regioselective Metabolism: Different in Vitro Metabolism of Cephalomannine and Paclitaxel Drug Metab. Dispos., February 1, 2008; 36(2): 418 - 426. [Abstract] [Full Text] [PDF]

				H. S. Brown, A. Chadwick, and J. B. Houston Use of Isolated Hepatocyte Preparations for Cytochrome P450 Inhibition Studies: Comparison with Microsomes for Ki Determination Drug Metab. Dispos., November 1, 2007; 35(11): 2119 - 2126. [Abstract] [Full Text] [PDF]

				M. Martignoni, G. Groothuis, and R. de Kanter COMPARISON OF MOUSE AND RAT CYTOCHROME P450-MEDIATED METABOLISM IN LIVER AND INTESTINE Drug Metab. Dispos., June 1, 2006; 34(6): 1047 - 1054. [Abstract] [Full Text] [PDF]

				A. A. Mathias, L. Maggio-Price, Y. Lai, A. Gupta, and J. D. Unadkat Changes in Pharmacokinetics of Anti-HIV Protease Inhibitors during Pregnancy: The Role of CYP3A and P-glycoprotein J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1202 - 1209. [Abstract] [Full Text] [PDF]

				M. A. Alterman, B. Kornilayev, T. Duzhak, and D. Yakovlev QUANTITATIVE ANALYSIS OF CYTOCHROME P450 ISOZYMES BY MEANS OF UNIQUE ISOZYME-SPECIFIC TRYPTIC PEPTIDES: A PROTEOMIC APPROACH Drug Metab. Dispos., September 1, 2005; 33(9): 1399 - 1407. [Abstract] [Full Text] [PDF]

				Y. Kohno, S. Kitamura, S. Sanoh, K. Sugihara, N. Fujimoto, and S. Ohta METABOLISM OF THE {alpha},{beta}-UNSATURATED KETONES, CHALCONE AND TRANS-4-PHENYL-3-BUTEN-2-ONE, BY RAT LIVER MICROSOMES AND ESTROGENIC ACTIVITY OF THE METABOLITES Drug Metab. Dispos., August 1, 2005; 33(8): 1115 - 1123. [Abstract] [Full Text] [PDF]

				A.-L. Minn, H. Pelczar, C. Denizot, M. Martinet, J.-M. Heydel, B. Walther, A. Minn, H. Goudonnet, and Y. Artur CHARACTERIZATION OF MICROSOMAL CYTOCHROME P450-DEPENDENT MONOOXYGENASES IN THE RAT OLFACTORY MUCOSA Drug Metab. Dispos., August 1, 2005; 33(8): 1229 - 1237. [Abstract] [Full Text] [PDF]

				R.-J. Sanders, R. Ofman, F. Valianpour, S. Kemp, and R. J. A. Wanders Evidence for two enzymatic pathways for {omega}-oxidation of docosanoic acid in rat liver microsomes J. Lipid Res., May 1, 2005; 46(5): 1001 - 1008. [Abstract] [Full Text] [PDF]

				R. K. Dubey, E. K. Jackson, D. G. Gillespie, M. Rosselli, F. Barchiesi, A. Krust, H. Keller, L. C. Zacharia, and B. Imthurn Cytochromes 1A1/1B1- and Catechol-O-Methyltransferase-Derived Metabolites Mediate Estradiol-Induced Antimitogenesis in Human Cardiac Fibroblast J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 247 - 255. [Abstract] [Full Text] [PDF]